[Follow] The growth rate of the pharmaceutical industry in our state leads the whole province

From January to July, the total output value of the pharmaceutical industry in the whole state was 8.52 billion yuan, exceeding the total number of last year, a year-on-year increase of 108.1%; the increase in value-added is 100.5%, the total pharmaceutical industry ranks second in the province, led the growth rate to lead the growth rate. The province has become an important engine to drive the total economic volume of the state.

In the field of traditional Chinese medicine, the development of the classic Chinese medicine classics has been launched one after another. Ao Dong Shihang has completed the merger and reorganization. The daily output of epidemic prevention of Chinese medicine reached 550,000 bags. At present, a total of 170 "Chinese Medicine Formula Granules Pilot Certificate" has been obtained. It is expected that the operating income of traditional Chinese medicine formula particles and other varieties this year will reach 150 million yuan.

In the field of Pharmaceutical, a new cooperation model for "Enterprise+Medical Institution+Scientific Institute" has been formed. A group of DPRK's clinical prescriptions were transformed and produced, and the treatment of tuberculosis was incorporated into the national green review channel, and the treatment of new drug development for the treatment of liver sclerosis Chaoshikang Pills.

In the field of chemical drugs, the capacity expansion of Jilin Kailai and the new varieties of Ao Dong Yanji will be put into production, and the elements are fully guaranteed to promote the continuous expansion of the production and sales of chemical drugs (raw medicines). In the first half of the year, most of the annual output of 35.6 tons of high -tech pharmaceuticals and annual output of 20.2 tons of high -tech pharmaceutical industrialization projects were completed and put into use. It is expected to be completed within the year. The first phase of the project of Kailaiying (Jilin) ​​Technology Company's high -tech pharmaceutical product production and research and development project is put into use. The second phase of the project is expected to be delivered in August this year. Strive for 3-5 years to build a number of industrialization projects for the construction of a batch of raw materials and preparations, accelerate the construction of Dunhua Pharmaceutical and Chemical Park, and achieve the development of the entire industrial chain of pharmaceuticals.

In the field of biopharmaceuticals, the PEG workshop of Jilin Jinpai Pharmaceuticals has entered large -scale production and has completed the annual batch production tasks of polyethylene galfenol; a number of new and technical reform projects such as Gute Biotechnology and Ao Teng Biotechnology have successively started.

In the field of medical device, our state actively responded to the prevention and control of epidemic, and the production capacity of epidemic prevention materials was greatly improved. Kexi'an medical device has a strong production and sales; Donghua Yuan medical device is officially put into production to achieve intelligent integration of medical examination equipment; the Guangyi pharmaceutical and health industry incubator based on the development of medical device incubation is about to be put into use.

- END -